Protara Therapeutics TARA
NASDAQ TARA
$3.19 -0.02 (-0.62%)
As of: Sep 30, 2026 · 9:34 AM EDT

Protara Therapeutics (TARA) Non-Current Assets (2013 - 2026)

Updated

Protara Therapeutics (TARA) reported Non-Current Assets of $29.94 million for Q2 2026, down 6.0% from $31.84 million a year earlier and down 42.3% from the prior quarter.

Analysis

Protara Therapeutics (TARA) Non-Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Protara Therapeutics posted Non-Current Assets of $49.96 million, up 437.3% from FY2024.

  • Non-Current Assets has a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
  • By year, Non-Current Assets came in at $9.3 million in FY2024 (-9.3%), $10.25 million in FY2023 (-62.2%), $27.14 million in FY2022 (-65.8%) and $79.48 million in FY2021 (+135.7%).
  • Five-year quarterly Non-Current Assets spans a low of $8.99 million in Q3 2025 and a high of $85 million in Q3 2021.
  • Year over year, Non-Current Assets gained in four of the last eight quarters, with growth averaging 122.3%.
  • The high point for year-over-year Non-Current Assets in five years was Q4 2025 (growth of 437.3%); the low point was Q1 2023 (a decline of 83.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $51.93 million (Q1 2026), $49.96 million (Q4 2025) and $8.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Protara Therapeutics 192.02 Mn 192.02 Mn - 29.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.94 Mn
Mar 31, 2026 51.93 Mn
Dec 31, 2025 49.96 Mn
Sep 30, 2025 8.99 Mn
Jun 30, 2025 31.84 Mn
Mar 31, 2025 42.03 Mn
Dec 31, 2024 9.30 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 9.43 Mn
Mar 31, 2024 10.22 Mn
Dec 31, 2023 10.25 Mn
Sep 30, 2023 10.65 Mn
Jun 30, 2023 10.88 Mn
Mar 31, 2023 11.79 Mn
Dec 31, 2022 27.14 Mn
Sep 30, 2022 49.92 Mn
Jun 30, 2022 53.79 Mn
Mar 31, 2022 70.57 Mn
Dec 31, 2021 79.48 Mn
Sep 30, 2021 85.00 Mn
API Access

Protara Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=TARA&period=max&api_key=YOUR_API_KEY